BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (NASDAQ:NRGN), a drug development company, announced today that it will release its third quarter 2008 financial results on Friday, November 7, 2008 before the opening of the U.S. financial markets. The Company will host a conference call and live audio webcast that same day at 8:30 a.m. ET to review the results.
The news release and live webcast may be accessed through the investor relations section of the Company’s web site: www.neurogen.com. The webcast will also be archived in this section, under “Events Calendar and Replays.”
About Neurogen
Neurogen Corporation is a drug development company focusing on small-molecule drugs to improve the lives of patients suffering from psychiatric and neurological disorders with significant unmet medical need. Neurogen conducts its drug development independently and, when advantageous, collaborates with world-class pharmaceutical companies to access additional resources and expertise.
